Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
13.84
+0.77 (5.89%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Adlai Nortye Revenue
In the year 2025, Adlai Nortye had annual revenue of $5.00M. Adlai Nortye had revenue of $5.00M in the half year ending December 31, 2025.
Revenue (ttm)
$5.00M
Revenue Growth
n/a
P/S Ratio
110.72
Revenue / Employee
$45,872
Employees
109
Market Cap
553.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 45.73M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Arvinas | 316.70M |
| ARS Pharmaceuticals | 98.99M |
| Autolus Therapeutics | 92.62M |
| 4D Molecular Therapeutics | 88.24M |
| Assembly Biosciences | 71.10M |
| Verastem | 49.59M |
| Prime Medicine | 4.07M |
| Shattuck Labs | 1.00M |
ANL News
- 3 days ago - Adlai Nortye submits clinical trial notification to Australia TGA for AN4035 - TheFly
- 4 days ago - Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia - GlobeNewsWire
- 22 days ago - Adlai Nortye doses first patient in AN9025 trial - TheFly
- 22 days ago - Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 - GlobeNewsWire
- 25 days ago - Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists - GlobeNewsWire
- 6 weeks ago - Cantor starts Adlai Nortye at Overweight, sees 180% upside - TheFly
- 6 weeks ago - Adlai Nortye initiated with an Overweight at Cantor Fitzgerald - TheFly
- 2 months ago - Adlai Nortye Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts